<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Alterity Therapeutics Limited

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases. Alterity Therapeutics was incorporated in Melbourne, Australia in 1997 as Prana Biotechnology and has offices in Melbourne, Australia, and San Francisco, USA. The Company listed on the Australian Securities Exchange in 2000 and listed on the NASDAQ in 2002. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Geoffrey Kempler
    • FOUNDED
      1997
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Cesca Therapeutics Inc.

    Cesca Therapeutics Inc.

    Cesca is a leading regenerative medicine company that develops, commercializes and...

    Cesca is a leading regenerative medicine compan...

    Filing Type:    PU
    Sol-Gel Technologies Ltd.

    Sol-Gel Technologies Ltd.

    Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing...

    Sol-Gel is a clinical-stage specialty pharmaceu...

    Filing Type:    PU
    resTORbio, Inc.

    resTORbio, Inc.

    resTORbio, Inc. is a clinical-stage biopharmaceutical company developing innovativ...

    resTORbio, Inc. is a clinical-stage biopharmace...

    Filing Type:    PU
    Tocagen Inc.

    Tocagen Inc.

    Tocagen is a clinical-stage, cancer-selective gene therapy company developing firs...

    Tocagen is a clinical-stage, cancer-selective g...

    Filing Type:    PU
    Alnylam Pharmaceuticals, Inc.

    Alnylam Pharmaceuticals, Inc.

    Alnylam is leading the translation of RNA interference (RNAi) into a whole new cla...

    Alnylam is leading the translation of RNA inter...

    Filing Type:    PU
    VistaGen Therapeutics, Inc.

    VistaGen Therapeutics, Inc.

    VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company...

    VistaGen Therapeutics (NASDAQ: VTGN) is a clini...

    Filing Type:    PU
    Neurotrope, Inc.

    Neurotrope, Inc.

    Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...

    Neurotrope is a clinical-stage biotech company ...

    Filing Type:    PU
    WindowMirror Inc

    WindowMirror Inc

    WindowMirror's BUTTERFLY will be a collaborative SaaS (Software as a Service) plat...

    WindowMirror's BUTTERFLY will be a collaborativ...

    Amount Raised:    $14,462.00
    Fundraising Status:    EC
    Filing Type:    CF
    Prevail Therapeutics Inc.

    Prevail Therapeutics Inc.

    Prevail Therapeutics is applying precision medicine to the development of gene the...

    Prevail Therapeutics is applying precision medi...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.